BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Julphar
US Army
Medtronic
Fuji
Deloitte
Moodys
Covington
Farmers Insurance
Chinese Patent Office

Generated: January 23, 2018

DrugPatentWatch Database Preview

Claims for Patent: 7,365,205

« Back to Dashboard

Summary for Patent: 7,365,205
Title:Diamine derivatives
Abstract: A compound represented by the general formula (1): Q.sup.1-Q.sup.2-T.sup.0-N(R.sup.1)-Q.sup.3-N(R.sup.2)-T.sup.1-Q.sup.4 (1) wherein R.sup.1 and R.sup.2 are hydrogen atoms or the like; Q.sup.1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q.sup.2 is a single bond or the like; Q.sup.3 is a group ##STR00001## in which Q.sup.5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T.sup.0 and T.sup.1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
Inventor(s): Ohta; Toshiharu (Tokyo, JP), Komoriya; Satoshi (Tokyo, JP), Yoshino; Toshiharu (Tokyo, JP), Nagamochi; Masatoshi (Tokyo, JP), Ono; Makoto (Tokyo, JP)
Assignee: Daiichi Sankyo Company, Limited (Tokyo, JP)
Application Number:10/481,262
Patent Claims: 1. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-(4-[(dimethylamino)carbonyl]-2-- {[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}c- yclohexyl)ethanediamide, a salt thereof, ##STR00801##

2. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-(4-[(dimethylamino)carbonyl]-2-- {[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}c- yclohexyl)ethanediamide p-toluenesulfonate ##STR00802##

3. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-(4-[(dimethylamino)carbonyl]-2-- {[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}c- yclohexyl)ethanediamide p-toluenesulfonate monohydrate ##STR00803##

4. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-((1S,2R,4S)-4-[(dimethylamino)c- arbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbo- nyl]amino}cyclohexyl)ethanediamide, a salt thereof, ##STR00804##

5. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-((1S,2R,4S)-4-[(dimethylamino)c- arbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbo- nyl]amino}cyclohexyl)ethanediamide p-toluenesulfonate. ##STR00805##

6. N.sup.1-(5-chloropyridin-2-yl)-N.sup.2-((1S,2R,4S)-4-[(dimethylamino)c- arbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbo- nyl]amino}cyclohexyl)ethanediamide p-toluenesulfonate monohydrate ##STR00806##

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Baxter
Chinese Patent Office
Medtronic
Federal Trade Commission
Cipla
Colorcon
UBS
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot